RGEN
Repligen Corporation
Stock
$181.70+4.47 (+2.52%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $785M | +15.0% |
| Gross profit | $423M | +13.0% |
| Operating income | $65M | −4.6% |
| Net income | $42M | −4.0% |
| EPS | $0.73 | −5.0% |
| Free cash flow | $112M | +18.5% |